About Genetix Biotech
Genetix Biotech is a company based in New Delhi (India) founded in 1988. It operates as a B2B. The company has 127 employees. Genetix Biotech offers products and services including DNASure Blood Mini Kit, RNASure Virus Kit, Automated Microplate ELISA Reader, High Speed Centrifuge, and Viral Transport Medium Sample Collection Kit. Genetix Biotech operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Teknova, Meridian Bioscience and BBI Solutions, among others.
- Headquarter New Delhi, India
- Employees 127
- SectorsHealthcare
- Email••••••••
- Website genetixbiotech.com
- Social X Facebook
- Legal Name Genetix Biotech Asia Limited
- Date of Incorporation 10 Oct, 2001
- Jurisdiction Delhi, India
- Annual Revenue₹207 Cr
FY 2024 · +26% YoY
- Net Profit₹30.18 Cr
FY 2024 · 15% margin
- EBITDA₹49.06 Cr
FY 2024 · 24% margin
- Employee Count127
Associated legal entities of Genetix Biotech
Genetix Biotech is associated with 2 registered companies on The Company Check; the primary company is Genetix Biotech Asia Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genetix Biotech Asia Limited CIN U24239DL2001PLC112768 | Active | 10 Oct 2001 | Delhi, Delhi | ₹207 Cr | 127 | 9 | View details |
| Victor Bio Genetics Private Limited CIN U74999TG2018PTC123961 | Active | 19 Apr 2018 | Secunderabad, Telangana | ₹37.3 Cr | 31 | 2 | View details |
Products & Services of Genetix Biotech
Genetix Biotech offers a comprehensive portfolio of products and services, including DNASure Blood Mini Kit, RNASure Virus Kit, Automated Microplate ELISA Reader, High Speed Centrifuge, and Viral Transport Medium Sample Collection Kit.
Kit for extracting DNA from blood samples for research purposes
Kit designed for RNA extraction from viral samples
Device for reading ELISA assays in diagnostic applications
Centrifuge for high-speed sample processing in labs
Kit for collecting and transporting viral samples safely
Board of directors of Genetix Biotech Asia Limited (Genetix Biotech)
Genetix Biotech Asia Limited is the primary company behind Genetix Biotech. The boards of the 2 registered companies of Genetix Biotech currently have 9 directors; the longest-serving is Arun Prakash, appointed in 2001. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Arun Prakash DIN 00287125 | Managing Director | 10 Oct 2001 | 25 yrs | Genetix Biotech Asia Limited |
| Raminder Kaur DIN 00287173 | Whole-time director | 10 Oct 2001 | 25 yrs | Genetix Biotech Asia Limited |
| Srinivasa Thota Rao DIN 03551487 | Managing Director | 19 Apr 2018 | 8 yrs 5 mo | Victor Bio Genetics Private Limited |
| Sridevi Thota DIN 06732398 | Director | 19 Apr 2018 | 8 yrs 5 mo | Victor Bio Genetics Private Limited |
| Poonam Deep DIN 08742398 | Director | 16 May 2020 | 6 yrs 4 mo | Genetix Biotech Asia Limited |
| Sandeep Aggarwal DIN 07627728 | CFO | 29 Jul 2024 | 2 yrs 2 mo | Genetix Biotech Asia Limited |
| Rakesh Kumar Dubey DIN 00174010 | Director | 18 Nov 2024 | 1 yr 10 mo | Genetix Biotech Asia Limited |
| Samuel John Farrimond DIN 10853596 | Director | 11 Dec 2024 | 1 yr 9 mo | Genetix Biotech Asia Limited |
| Navin Chandra Khanna DIN 00714222 | Director | 08 Feb 2025 | 1 yr 8 mo | Genetix Biotech Asia Limited |
Financials of Genetix Biotech
Figures of Genetix Biotech Asia Limited, the primary company behind Genetix Biotech, for FY 2024. Revenue was ₹207 Cr (+26% year on year). Net profit was ₹30.18 Cr (15% margin). EBITDA was ₹49.06 Cr (24% margin).
- ₹207 CrRevenue · FY 2024 · +26% YoY
- ₹30.18 CrNet profit · 15% margin
- ₹49.06 CrEBITDA · 24% margin
- ₹96.8 LakhPaid-up capital
- 127Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Genetix Biotech Asia Limited are on its company page.
Detailed financial statements for Genetix Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Genetix Biotech
Genetix Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Teknova, Meridian Bioscience and BBI Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| bbisolutions.com | 1986 | Crumlin, United Kingdom | – | 301 | Kits and reagents are developed for life science research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| biochain.com | 1994 | Hayward, United States | $7.34M | 24 | Provider of products and services for clinical diagnosis, genomics, and proteomics | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| enzo.com | 1976 | Farmingdale, United States | $7M | 179 | Developer of small molecules and gene delivery vectors |
Detailed competitors of Genetix Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genetix Biotech
The website of Genetix Biotech (genetixbiotech.com) receives about 5.5K visits a month.
- Monthly visits5.5K
▲ 92.5% vs previous month
Websites whose visitors overlap most with Genetix Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
bio-goods.com | bio-goods.com | 100% | – | #4,889,974 | – |
| elokarsa.com | 97% | – | #1,197,312 | View details | |
biosupplynet.com | biosupplynet.com | 96% | – | – | – |
clonagen.com | clonagen.com | 96% | – | #8,001,081 | – |
biowww.net | biowww.net | 96% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Genetix Biotech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Genetix Biotech
Complete news archive for Genetix Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Genetix Biotech
10 companies that operate in the same segment as Genetix Biotech (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genetix Biotech
Genetix Biotech was founded in 1988.
Genetix Biotech is headquartered in New Delhi, India. It is registered at New Delhi, Delhi, India.
Genetix Biotech has 127 employees.
The primary company behind Genetix Biotech, Genetix Biotech Asia Limited, reported revenue of ₹207 Cr for FY 2024, up 26% year on year.
Genetix Biotech Asia Pvt. Ltd. operates as a consultative partner in life sciences, offering a wide range of biotechnology products and services. They distribute brands like Bio-Rad and Sartorius, focusing on molecular biology, immunology, and lab equipment. Based in New Delhi, India, they serve sectors including research, academia, pharmaceuticals, and diagnostics. Their activities include product distribution and support for applications in tissue culture, chromatography, and quality control, catering to clients in various industries.
Genetix Biotech's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
Genetix Biotech offers DNASure Blood Mini Kit, RNASure Virus Kit, Automated Microplate ELISA Reader, High Speed Centrifuge, and Viral Transport Medium Sample Collection Kit.
Genetix Biotech is associated with 2 legal entities: Genetix Biotech Asia Limited, Victor Bio Genetics Private Limited.
The legal entities of Genetix Biotech currently have 10 directors, including Arun Prakash, Raminder Kaur, Navin Chandra Khanna and others.